JP2017522298A5 - - Google Patents

Download PDF

Info

Publication number
JP2017522298A5
JP2017522298A5 JP2016575397A JP2016575397A JP2017522298A5 JP 2017522298 A5 JP2017522298 A5 JP 2017522298A5 JP 2016575397 A JP2016575397 A JP 2016575397A JP 2016575397 A JP2016575397 A JP 2016575397A JP 2017522298 A5 JP2017522298 A5 JP 2017522298A5
Authority
JP
Japan
Prior art keywords
poly
amino acid
composition
compound
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016575397A
Other languages
English (en)
Japanese (ja)
Other versions
JP6494670B2 (ja
JP2017522298A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/036904 external-priority patent/WO2015200180A1/en
Publication of JP2017522298A publication Critical patent/JP2017522298A/ja
Publication of JP2017522298A5 publication Critical patent/JP2017522298A5/ja
Application granted granted Critical
Publication of JP6494670B2 publication Critical patent/JP6494670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016575397A 2014-06-27 2015-06-22 ビタミンdに関連する組成物 Active JP6494670B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462018008P 2014-06-27 2014-06-27
US62/018,008 2014-06-27
PCT/US2015/036904 WO2015200180A1 (en) 2014-06-27 2015-06-22 Compositions relating to vitamin d

Publications (3)

Publication Number Publication Date
JP2017522298A JP2017522298A (ja) 2017-08-10
JP2017522298A5 true JP2017522298A5 (cg-RX-API-DMAC7.html) 2018-08-30
JP6494670B2 JP6494670B2 (ja) 2019-04-03

Family

ID=54938699

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016575397A Active JP6494670B2 (ja) 2014-06-27 2015-06-22 ビタミンdに関連する組成物

Country Status (9)

Country Link
US (2) US10106498B2 (cg-RX-API-DMAC7.html)
EP (1) EP3177297B1 (cg-RX-API-DMAC7.html)
JP (1) JP6494670B2 (cg-RX-API-DMAC7.html)
KR (1) KR102528381B1 (cg-RX-API-DMAC7.html)
CN (1) CN106470684B (cg-RX-API-DMAC7.html)
AU (1) AU2015280290B2 (cg-RX-API-DMAC7.html)
BR (2) BR112016030507B1 (cg-RX-API-DMAC7.html)
ES (1) ES2877562T3 (cg-RX-API-DMAC7.html)
WO (1) WO2015200180A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3172239A4 (en) * 2014-06-27 2017-06-21 Siemens Healthcare Diagnostics Inc. Binding partners specific for vitamin d epimers
WO2016100117A2 (en) 2014-12-17 2016-06-23 Siemens Healthcare Diagnostics Inc. Accurate assay measurement of hydrophobic haptenic analytes
CN107652302B (zh) * 2016-07-25 2020-09-15 深圳迈瑞生物医疗电子股份有限公司 化合物、缀合物、试剂盒及其用途
CN110381919A (zh) 2017-03-03 2019-10-25 西梯茜生命工学股份有限公司 含有伐尼克兰或其药学上可接受的盐的包合复合物的口服施用制剂
CN116143692B (zh) * 2019-02-01 2025-09-16 科美博阳诊断技术(上海)有限公司 用于测定维生素d的含量或存在的化合物、产品和方法
CN111474341B (zh) * 2020-04-28 2023-09-29 上海泰辉生物科技有限公司 基于免疫比浊和余辉发光的均相联合检测试剂和检测方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09143154A (ja) 1995-11-20 1997-06-03 Kureha Chem Ind Co Ltd ビタミンd3 誘導体の製造方法
DE873126T1 (de) * 1995-12-29 2000-11-02 A And D Assay, Inc. Markierte vitamin d-verbindungen und deren verwendung
DE19981132D2 (de) * 1998-06-25 2001-10-18 Immundiagnostik Ges Fuer Produ Funktionelle Vitamin-D-Derivate und Verfahren zur Bestimmung von 25-Hydroxy- und 1alpha,25-Dihydroxy-Vitamin-D
US8133694B2 (en) 1998-06-25 2012-03-13 Immundiagnostik Ag Functional vitamin D derivatives and method of determining 25-hydroxy- and 1α, 25-dihydroxy vitamin D
US7253293B2 (en) 2004-01-06 2007-08-07 Andrzej Slominski Enzymatic method to produce 7-dehydropregnenolone, vitamin D3-like compounds and derivatives thereof
US20100144671A1 (en) 2005-03-04 2010-06-10 Women And Infants Hospital Of Ri, Inc. Compositions and Methods for Cancer Treatment
CN100431374C (zh) * 2005-06-28 2008-11-05 上海原动力通信科技有限公司 高速下行分组接入业务用户终端在多载波小区的工作方法
US8785603B2 (en) 2011-05-20 2014-07-22 Siemens Healthcare Diagnostics Inc. Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
KR20220051197A (ko) * 2012-05-17 2022-04-26 익스텐드 바이오사이언시즈, 인크. 개선된 약물 전달용 캐리어
WO2014085486A2 (en) 2012-11-30 2014-06-05 Waters Technologies Corporation Methods and apparatus for the analysis of vitamin d metabolites
US9244083B2 (en) 2012-11-30 2016-01-26 Siemens Healthcare Diagnostics Inc. Compositions and methods for detecting vitamin D
US9618523B2 (en) 2013-02-28 2017-04-11 Siemens Healthcare Diagnostics Inc. Methods and reagents for determining isomeric analytes
US20140308751A1 (en) 2013-04-12 2014-10-16 Siemens Healthcare Diagnostics Inc. Assays for Analyte Homologs
ES2853525T3 (es) * 2014-06-27 2021-09-16 Siemens Healthcare Diagnostics Inc Parejas de unión específicas para epímeros de vitamina D en ensayos de vitamina D
KR20170015527A (ko) * 2014-06-27 2017-02-08 지멘스 헬쓰케어 다이아그노스틱스 인크. 비타민 d 에피머에 대한 검정 방법
EP3172239A4 (en) * 2014-06-27 2017-06-21 Siemens Healthcare Diagnostics Inc. Binding partners specific for vitamin d epimers

Similar Documents

Publication Publication Date Title
JP2017522298A5 (cg-RX-API-DMAC7.html)
JP2007514047A5 (cg-RX-API-DMAC7.html)
JP2022043078A5 (cg-RX-API-DMAC7.html)
JP2013028597A5 (cg-RX-API-DMAC7.html)
JP2004536134A5 (cg-RX-API-DMAC7.html)
ES2422204T3 (es) Novedosos derivados de imidazolidin-2-ona como moduladores selectivos de receptor de andrógenos (SARMS)
JP2014028784A5 (ja) 複素環化合物および有機化合物
JP2013010749A5 (ja) カルバゾール化合物
JP2013063963A5 (ja) 複素環化合物
ES2254047T1 (es) Procedimiento de preparacion de derivados de topiramato anticonvulsivos.
JP2014029971A5 (ja) 有機化合物
DK1678119T3 (da) Fremgangsmåde til fremstilling af 2-dihalogenacyl-3-amino-acrylsyreestere og 3-dihalogenmethyl-pyrazol-4-carboxylsyreestere
JP2007063501A5 (cg-RX-API-DMAC7.html)
JP2010071995A5 (cg-RX-API-DMAC7.html)
JP2010525122A5 (cg-RX-API-DMAC7.html)
BRPI0516221A (pt) método de produção de vìrus de uma cultura de células, composição, e, método de produção de reovìrus infeccioso
BR0309659A (pt) Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso
JP2013131743A5 (cg-RX-API-DMAC7.html)
JP2007523139A5 (cg-RX-API-DMAC7.html)
JP2010519289A5 (cg-RX-API-DMAC7.html)
JP2013118368A5 (ja) ジベンゾ[f,h]キノキサリン化合物
AR065795A1 (es) Derivados de aza-piridopirimidinona,metodo de preparacion,medicamentos que los contienen y usos como agentes antitromboticos, antihiperlipidemicos y antidiabeticos,entre otros.
ES2531396T3 (es) Proceso para preparar compuestos de piridinona
JP2009298770A5 (cg-RX-API-DMAC7.html)
JP2022008106A5 (cg-RX-API-DMAC7.html)